000			02141 a2200613 4500
005			20250513211333.0
264		0	_c20000601
008			200006s 0 0 eng d
022			_a0008-543X
024	7		_a10.1002/(sici)1097-0142(20000501)88:9<2054::aid-cncr11>3.0.co;2-j _2doi
040			_aNLM _beng _cNLM
100	1		_aHoff, P M
245	0	0	_aCombined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy. _h[electronic resource]
260			_bCancer _cMay 2000
300			_a2054-60 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents, Hormonal _xadverse effects
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCarcinoma _xdrug therapy
650	0	4	_aDisease
650	0	4	_aDisease-Free Survival
650	0	4	_aEndometrial Neoplasms _xchemically induced
650	0	4	_aEstrogen Antagonists _xadverse effects
650	0	4	_aFeasibility Studies
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aFrail Elderly
650	0	4	_aHumans
650	0	4	_aMastectomy, Segmental
650	0	4	_aMiddle Aged
650	0	4	_aNeoadjuvant Therapy
650	0	4	_aNeoplasm Recurrence, Local _xpathology
650	0	4	_aNeoplasm Staging
650	0	4	_aReceptors, Estrogen _xanalysis
650	0	4	_aRemission Induction
650	0	4	_aSelective Estrogen Receptor Modulators _xadverse effects
650	0	4	_aSurvival Rate
650	0	4	_aTamoxifen _xadverse effects
650	0	4	_aTreatment Outcome
700	1		_aValero, V
700	1		_aBuzdar, A U
700	1		_aSingletary, S E
700	1		_aTheriault, R L
700	1		_aBooser, D
700	1		_aAsmar, L
700	1		_aFrye, D
700	1		_aMcNeese, M D
700	1		_aHortobagyi, G N
773	0		_tCancer _gvol. 88 _gno. 9 _gp. 2054-60
856	4	0	_uhttps://doi.org/10.1002/(sici)1097-0142(20000501)88:9<2054::aid-cncr11>3.0.co;2-j _zAvailable from publisher's website
999			_c10765507 _d10765507